BC
GMED icon

Brookfield Corp’s Globus Medical GMED Stock Holding History

Brookfield Corp’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,329
Closed -$982K – 658
2023
Q1 		$982K Buy
+17,329
New +$1.11M ﹤0.01% 509
2021
Q4 		– Sell
-42,995
Closed -$3.29M – 683
2021
Q3 		$3.29M Buy
+42,995
New +$3.45M 0.01% 277

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Brookfield Corp's GMED Position: Q2 2023 in Review

Brookfield Corp sold out of Globus Medical (GMED) in Q2 2023, closing a stake of 17,329 shares — an estimated $982K sold.

Brookfield Corp first reported a position in GMED in Q3 2021 and held it in 2 quarters. The position peaked at $3.29M in Q3 2021. 381 funds tracked by Wall St. Rank hold GMED as of Q2 2023.

  • Brookfield Corp reported no remaining Globus Medical position as of Q2 2023 after selling out during the quarter.
  • Brookfield Corp sold 17,329 Globus Medical shares in Q2 2023, an estimated $982K.
  • Brookfield Corp first reported a position in Globus Medical in Q3 2021 and held it in 2 quarters.
  • Brookfield Corp's Globus Medical position peaked at $3.29M in Q3 2021.
  • 381 funds tracked by Wall St. Rank held Globus Medical as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.